People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

Peter Salgo, MD, notes that type 2 diabetes mellitus (T2DM) is associated with multiple metabolic defects. Traditional agents (eg, metformin, TZDs, and sulfonylureas) target insulin production and ...

Treatment with liraglutide (3.0 mg once daily for 3 years), a glucagon-like peptide 1 receptor agonist that lowers levels of glucose and reduces body weight, reduced the risk of 'on treatment' type 2 ...

Treatment effect is greater in patients with dyslipidemia; absolute risk reduction of 2.15 percent (HealthDay News) — For individual patients with type 2 diabetes mellitus (T2DM), the effect of ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired ...

NKF 2017-prescription pill bottles, capsule pills Treatment effect is greater in patients with dyslipidemia; absolute risk reduction of 2.15% (HealthDay News) — For individual patients with type 2 ...

Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.

Little is known about the impacts of therapy on adolescent patients with T2DM. In a recent study, adolescents with newly diagnosed T2DM had profound impairment of beta-cell function, but treatment ...

hba1c hemoglobin diabetes test A new study published in JAMA Internal Medicine found that over 20% of patients with type 2 diabetes were given intensive treatment that was potentially unnecessary and ...

Polyneuropathy occurs when multiple peripheral nerves malfunction throughout the body. Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). Polyneuropathy occurs when there is ...